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Abstract  
This article is an outcome of the African Craniofacial Anomalies Research Network (AfriCRAN) Human Hereditary and Health (H3A) grant planning 
meeting in 2012 in Lagos, Nigeria. It describes the strengths of a multidisciplinary team approach to solving complex genetic traits in the 
craniofacial region. It also highlights the different components and argues for the composition of similar teams to fast track the discovery of 
disease genes, diagnostic tools, improved clinical treatment and ultimately prevention of diseases. 
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Introduction 
 
As we gradually and deliberately move towards the era of 
personalized medicine, it is important to understand the diversity 
that exists in the human genome. Emerging technologies and tools 
have made it possible to understand the molecular mechanisms 
underlying disease progression. Scientists are now able to 
interrogate the genome in order to determine the role of functional 
loci in coding and non-coding regions [1]. Clearly, we have made 
tremendous progress in the quest to use the knowledge of the 
genome to treat and prevent human diseases. Genomic studies in 
Africa is witnessing the best of times with the establishment of the 
Human , Hereditary and Health Africa (H3A) initiative supported by 
the NIH and Welcome Trust. The H3A was established to develop 
and support a continent-wide network of scientists and laboratories 
that will use "state of the art" approaches and technologies to the 
study of the complex interaction between environmental and 
genetic factors in disease etiology and pathogenicity. This initiative 
will also explore drug responses in African populations. The ultimate 
goal of the H3A is to use data obtained from research efforts to 
influence and inform strategies that will address health inequities. 
This is line with the vision of the WHO Global Burden of Diseases 
and the Global Oral Health Inequalities Research Network (GOHIRN) 
of the International Association for Dental Research. These global 
efforts and strategies will bring health benefits to Africans and 
indeed the World. Craniofacial conditions are amongst the most 
common health disparities and one of the leading causes of health 
inequality affecting low-income countries in the world [2]. In Africa, 
craniofacial disparity is being addressed by studying orofacial clefts 
through the African Craniofacial Anomalies Research Network 
(AfriCRAN). The African Craniofacial Anomalies Network (AfriCRAN) 
is a collection of craniofacial researchers in Africa working with 
international collaborators in order to collect data on genetic 
variations and environmental exposures from individuals and 
families with craniofacial abnormalities in Africa. These resources 
will be used to investigate the etiology of these complex traits and 
to serve as a basis for more extensive studies in the future. The 
Network´s major strength is its people, who bring their 
commitment, and expertise to this collaboration and who will be 
responsible for the Network's strong continental and international 
capacity. Orofacial cleft (OFC) is the most common birth defect of 
the head and one of the most common birth defects in humans. The 
overall prevalence is 1/700 live births and this differs across ethnic 
groups [2]. Orfacial cleft serve as a sentinel for all birth defects and 
therefore a good model for studies on etiology, treatment and 
prevention. The prevalence of overt OFC in Africa is 0.5/1000 and 
this is low compared to other populations [3]. Understanding the 
etiology of OFC in this unique population will provide additional 
insights into the etiology and this will be important for studies on 
prevention. In this article, we will highlight how AfriCRAN is 
leveraging on its multidisciplinary composition to carryout genomic 
studies on craniofacial anomalies beginning with orofacial clefts.  
  
  
Letter to PAMJ editors 
 
Phenotyping  
  
An essential pre-requisite for studies on human genetics is accurate 
and reliable phenotyping. Phenotypes are sets of observable 
characteristics and they are the product of the interaction between 
genotype (s) and the environment. In other words, phenotypes are 
the reflections of the nature and the nurture of an organism [4]. 
Phenotypes can be physical reflections or metabolic profiles that can 
be measured by some form of validated metrics. In AfriCRAN, our 
study coordinators in participating country are surgeons in different 
specialties (plastic surgery, ear nose and throat surgeons, pediatric 
surgeons, maxillofacial surgeons and dental surgeons). Using their 
individual and collective expertise, the surgeons and clinicians 
ensure that eligible cases are accurately phenotyped. For all the 
cases recruited, the surgeons carry out standardized physical 
examinations; take clinical photographs and record the full 
description of cleft phenotypes and all other recognizable 
malformations. All data obtained are entered into a secured Redcap 
database [5]. Centers also have access to echocardiogram and 
electrocardiogram results to rule out other heart defects. A second 
tier of phenotyping is done in collaboration with international 
collaborators in Iowa where there is expertise for detecting 
syndromes. We carry out regular reviews of cases as quality 
assurance before the genomic investigations. In a recent study, we 
used molecular techniques to tease out syndromic cases previously 
classified as non-syndromic clefts [6]. Our strategy is to make every 
opportunity for surgery available for research. Individuals are 
recruited through the hospitals and community surgical outreach 
programs in Nigeria, Ethiopia, Ghana, Kenya and Rwanda. Samples 
from the affected individual are collected in the hospital by the 
surgeons who also describe the phenotypes. AfriCRAN enjoys the 
services of specialist registrars and nurses who are employed as 
research assistants. These research personnel help in data collection 
from cleft subjects and their parents as well as unaffected controls.  
  
Molecular genetics applications  
  
The ultimate goal in any genetic research is to reduce the risk for 
the disease and to facilitate strategies for prevention. As we 
approach the era of personalized medicine, studies have argued that 
it is important to investigate diverse populations in the study of 
complex diseases [7-9]. The discoveries of candidate genes for 
orofacial clefts has benefitted from studies that included individuals 
from different populations. The first gene, IRF6 reported to be 
significantly associated with Van der Woude syndrome (VWS), 
Popliteal pterygium syndrome and non-syndromic clefts was first 
identified in monozygotic twins with Van der Woude syndrome 
(VWS) from Brazil [10]. Genome-wide association studies (GWAS) 
provided additional evidence supporting the need to investigate 
diverse population groups for a complex trait such as CL(P) [11-13]. 
The African populations serve as the ancestral population to humans 
around the world and the African genome has accumulated the 
greatest genetic variations [14, 15]. The genomic era is witnessing 
the large scale sequencing of many personal genomes to 
understand disease etiology, mechanisms and diagnosis. This is 
possible through the success of GWAS for common, complex 
diseases and the reducing cost of generating data using high 
throughput technology. A vast majority of GWAS studies including 
those on non-syndromic orofacial clefts has been conducted in 
populations of European origin with only a few focused on Asian or 
African populations. We believe that an investigation of the genetic 
variations in these related populations across the world affords 
better opportunities to identify new risk genes/ loci. It will also 
provide an opportunity to understand the differential contributions 
of known candidate genes. These opportunities will expand our 
current understanding of these complex traits and provide the 
potentials for translating significant findings to affected individuals 
and families in other populations. These findings will bring forth 
several opportunities geared towards the design of accurate 
diagnostic and predictive markers, improved molecularly based 
treatment and better health for Africans and the world. The 
AfriCRAN is well suited to carryout genome-wide studies using a 
large cohort of orofacial cleft samples collected in countries from 
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sub-Saharan Africa. The network works in collaboration with 
international partners at centers of excellence in Iowa, NIH and 
Pittsburgh in the United States, Dundee in the United Kingdom and 
Ottawa in Canada.  
  
Bio-informatics  
  
We work with scientists at the South African National Bio-informatics 
Institute (SANBI) who has substantial experience in bioinformatics 
research and genomics. This group specializes in elucidating the 
genetics underlying human disease using computational 
approaches, particularly in the African context. SANBI has the 
capacity to host a centralized relational database, with appropriate 
data fidelity, security and backup. Patient and sample details will be 
entered and accessed by consortium members through a browser-
based, user-friendly front-end form. Additionally, SANBI will 
undertake processing of next generation sequencing data (genome 
and exome), functional SNP identification, and integration of data 
generated with gene and pathway analysis to determine clinical and 
biological meaning of disease-associated variation. Presently, SANBI 
works closely with the Bioinformatics department at Covenant 
University, Ogun State, Nigeria, as well as the H3 Africa 
Bioinformatics Network. SANBI is well-placed for this role, given that 
development of pipelines for analysis of next generation sequencing 
data is already underway at the Institute through an NIH funded 
H3A Bioinformatics Network.  
  
Bioethics  
  
Craniofacial anomalies are surrounded with considerable 
superstitions stemming from cultural beliefs in many countries on 
the African continent. Typically, children born with craniofacial 
anomalies are associated with ill omens, witchcrafts and are thought 
to be the consequence of an abuse by the gods on their mothers 
during pregnancy. The birth of children with orofacial clefts comes 
with some major concerns that include altercation in the families 
and infanticide (mainly due to deliberate aspiration of the affected 
child during breast feeding). Orofacial clefts are a matter of life and 
death in most part of Africa [16, 17]. Stigmatization of individuals 
and families is very common in Africa, where there is limited 
knowledge about the etiology and management of clefts (Adeyemo 
et al., unpublished) [18]. Across the continent, it is still a challenge 
to explain the etiology of these phenotypes to families. Translating 
significant findings from genetic studies that may directly impact on 
personalized medicine will definitely pose additional challenges. 
Genomics research into any type of diseases or conditions raise a 
number of important ethical issues relating to informed consent 
[19]; privacy and confidentiality [20, 21]; data sharing and 
secondary use (Foster and Sharp, 2006) [22]. These challenges are 
very important when research is conducted in countries with low 
socio-economic indices and education levels [23]. There are also 
challenges associated with obtaining a valid informed consent [24, 
25]. Genetic studies are extremely important and have provided 
significant insights into the etiology as well as clues to management 
and prevention [26-28]. They can also reveal hidden secrets about 
families e.g. risks for cancer, clefts etc [29-31]. Poorly managed 
information on these risks can add to pre-existing stigmatization, 
thus posing a challenge to the science community. For instance, in a 
study examining podoconiosis in Ethiopia, Tekola et al (2009) [25] 
found that the association of a stigmatized condition with "blood", 
descent and family was thought to increase stigma for the entire 
family, and not just those suffering from the condition (Tekola et 
al.,2009) [25]. In another study in the US, Phelan et al. (2005) [32] 
found that even though respondents were less likely to attribute 
blame for having schizophrenia to patients when a genetic cause 
was known, they were also less likely to think that the person could 
improve with treatment (Phelan et al.,2005) [32]. In recognition of 
socially important issues that can directly affect the success of 
future genetic studies, AfriCRAN is working with bioethicists across 
the continent to develop studies that will influence policy changes 
aimed at reducing and abolishing stigmatization.  
  
Prospects of a multidisciplinary team  
  
There is improvement in the knowledge of the genome and 
successes in the application of genomic studies to improve diagnosis 
and treatment. Multidisciplinary approach is the silver lining in the 
dark cloud that has befallen genetic studies of complex traits. As 
more experts avail their skills, techniques and thoughts to teams; it 
will only be a matter of time for the genomic world to have direct 
bench to bed side applications.  
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